QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 ubs-maintains-neutral-on-cryoport-lowers-price-target-to-7

UBS analyst Dan Leonard maintains CryoPort (NASDAQ:CYRX) with a Neutral and lowers the price target from $17 to $7.

 jefferies-downgrades-cryoport-to-hold-lowers-price-target-to-8

Jefferies analyst Matthew Stanton downgrades CryoPort (NASDAQ:CYRX) from Buy to Hold and lowers the price target from $20 to...

 needham-maintains-buy-on-cryoport-lowers-price-target-to-11

Needham analyst David Saxon maintains CryoPort (NASDAQ:CYRX) with a Buy and lowers the price target from $18 to $11.

 cryoport-q2-2024-adj-eps-029-beats-039-estimate-sales-57597m-miss-57684m-estimate

CryoPort (NASDAQ:CYRX) reported quarterly losses of $(0.29) per share which beat the analyst consensus estimate of $(0.39) by 2...

 cryoport-announces-200m-repurchase-program-and-the-repurchase-of-160m-of-convertible-senior-notes

$200 million repurchase program authorized to repurchase common stock and/or convertible notes Repurchasing approximately $160 ...

 b-riley-securities-upgrades-cryoport-to-buy-lowers-price-target-to-15

B. Riley Securities analyst Yuan Zhi upgrades CryoPort (NASDAQ:CYRX) from Neutral to Buy and lowers the price target from $1...

 cryoport-partners-with-minaris-regenerative-medicine-for-cell-and-gene-therapies-advancement

Partnership Will Provide Cell and Gene Therapy Industry with Fully Integrated Logistics and Manufacturing Services for Regenera...

 needham-reiterates-buy-on-cryoport-maintains-18-price-target

Needham analyst David Saxon reiterates CryoPort (NASDAQ:CYRX) with a Buy and maintains $18 price target.

 cryoport-q1-2024-gaap-eps-043-misses-035-estimate-sales-54592m-miss-58760m-estimate

CryoPort (NASDAQ:CYRX) reported quarterly losses of $(0.43) per share which missed the analyst consensus estimate of $(0.35) by...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION